Experimental validation of a theoretical model of cytokine capture using a hemoadsorption device
- PMID: 19680812
- PMCID: PMC2771882
- DOI: 10.1007/s10439-009-9780-4
Experimental validation of a theoretical model of cytokine capture using a hemoadsorption device
Abstract
Sepsis, a systemic inflammatory response in the presence of an infection, is characterized by overproduction of inflammatory mediators called cytokines. Removal of these cytokines using an extracorporeal hemoadsorption device is a potential therapy for sepsis. We are developing a cytokine adsorption device (CAD) filled with microporous polymer beads and have previously published a mathematical model which predicts the time course of cytokine removal by the device. The goal of this study was to show that the model can experimentally predict the rate of cytokine capture associated with key design and operational parameters of the CAD. We spiked IL-6, IL-10, and TNF into horse serum and perfused it through an appropriately scaled-down CAD and measured the change in concentration of the cytokines over time. These data were fit to the mathematical model to determine a single model parameter, Gamma( i ), which is only a function of the cytokine-polymer interaction and the cytokine effective diffusion coefficient in the porous matrix. We compared Gamma( i ) values, which by definition should not change between experiments. Our results indicate that the Gamma( i ) value for a specific cytokine was statistically independent of all other parameters in the model, including initial cytokine concentration, flow rate, serum reservoir volume, CAD size, and bead size. Our results also indicate that competitive adsorption of cytokines and other middle-molecular weight proteins, which is neglected in the model, does not affect the rate of removal of a given cytokine. The model of cytokine capture in the CAD developed in this study will be integrated with a systems model of sepsis to simulate the progression of sepsis in humans and to develop a therapeutic CAD design and intervention protocol that improves patient outcomes in sepsis.
Figures







Similar articles
-
Selective improvement of tumor necrosis factor capture in a cytokine hemoadsorption device using immobilized anti-tumor necrosis factor.J Biomed Mater Res B Appl Biomater. 2011 Jan;96(1):127-33. doi: 10.1002/jbm.b.31748. J Biomed Mater Res B Appl Biomater. 2011. PMID: 21086427 Free PMC article.
-
Modeling competitive cytokine adsorption dynamics within hemoadsorption beads used to treat sepsis.J Chromatogr A. 2011 Nov 4;1218(44):8013-20. doi: 10.1016/j.chroma.2011.09.007. Epub 2011 Sep 9. J Chromatogr A. 2011. PMID: 21962329 Free PMC article.
-
A simple mathematical model of cytokine capture using a hemoadsorption device.Ann Biomed Eng. 2009 Jan;37(1):222-9. doi: 10.1007/s10439-008-9587-8. Epub 2008 Oct 24. Ann Biomed Eng. 2009. PMID: 18949559 Free PMC article.
-
Blood and plasma treatments: the rationale of high-volume hemofiltration.Contrib Nephrol. 2007;156:387-95. doi: 10.1159/000102129. Contrib Nephrol. 2007. PMID: 17464149 Review.
-
Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design.Crit Care. 2002 Oct;6(5):394-6. doi: 10.1186/cc1826. Epub 2002 Sep 4. Crit Care. 2002. PMID: 12398774 Free PMC article. Review.
Cited by
-
Selective improvement of tumor necrosis factor capture in a cytokine hemoadsorption device using immobilized anti-tumor necrosis factor.J Biomed Mater Res B Appl Biomater. 2011 Jan;96(1):127-33. doi: 10.1002/jbm.b.31748. J Biomed Mater Res B Appl Biomater. 2011. PMID: 21086427 Free PMC article.
-
IL-6 adsorption dynamics in hemoadsorption beads studied using confocal laser scanning microscopy.J Biomed Mater Res B Appl Biomater. 2010 Feb;92(2):390-6. doi: 10.1002/jbm.b.31527. J Biomed Mater Res B Appl Biomater. 2010. PMID: 19904819 Free PMC article.
-
Modeling competitive cytokine adsorption dynamics within hemoadsorption beads used to treat sepsis.J Chromatogr A. 2011 Nov 4;1218(44):8013-20. doi: 10.1016/j.chroma.2011.09.007. Epub 2011 Sep 9. J Chromatogr A. 2011. PMID: 21962329 Free PMC article.
-
Modeling and Hemofiltration Treatment of Acute Inflammation.Processes (Basel). 2016;4(4):38. doi: 10.3390/pr4040038. Epub 2016 Oct 18. Processes (Basel). 2016. PMID: 33134139 Free PMC article.
References
-
- Bone RC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–1655. - PubMed
-
- Angus DC, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310. - PubMed
-
- Hotchkiss RS, Karl IE. Cytokine blockade in sepsis--Are two better than one? Crit Care Med. 2001;29(3):671–672. - PubMed
-
- Cross AS, Opal SM. A new paradigm for the treatment of sepsis: is it time to consider combination therapy? Ann Intern Med. 2003;138(6):502–505. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous